Vima »

Aurinia Pharmaceuticals shares owned by Vima

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Vima from 13F filings

Historical chart of Vima investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Vima consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Vima

Quarter filed Position value Share count Share price at filing
2023-12-31 $225 25 9.00

More positions owned by Vima

Invesco Exchange-traded Fd Tr S&p 500 Garp Etf Etf (SPGP)
Apple (AAPL)
Vaneck Etf Tr Gold Miners Etf Etf (GDX)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ishares Tr 20 Yr Treas Bd Etf Etf (TLT)
Berkshire Hathaway Inc Del Cl B Del Cl B New
Ishares Gold Tr Ishares Gold Tr (IAU)
Vanguard Malvern Fds Short-term Inflation Protected Secs Index Fd Etf FDS (VTIP)
Invesco Exchange-traded Fd Tr Ii Sr Ln Etf SR LN STF (BKLN)
Marathon Digital Holdings In (MARA)
John Hancock Exchange Traded Fd Tr Multifactor Mid Cap Etf Mid Cap Etf (JHMM)
First Tr Exchange-traded Fd Viii Ft Vest U S Equity Enhance & Equity Etf November TR (XNOV)
Ellsworth Fund (ECF)
First Tr Exchange-traded Fd Vii Alt Absolute Return Strategy Etf Etf (FAAR)

View all positions for Vima

Top funds holding Aurinia Pharmaceuticals

NEA Management Company
Goldman Sachs Group
Citadel Advisors
Vanguard Group
Citigroup
Balyasny Asset Management
Caption Management
Jane Street
Tang Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Stifel Financial
GSA Capital Partners
Nordea Investment Management Ab
Barclays

View all funds holding Aurinia Pharmaceuticals